bezlotoxumab (zinplava) Report issue

Biologics mAb Approved FDA Fast Track FDA Priority Review FDA

Active Ingredient History

  • Now
Bezlotoxumab, sold under the brand name Zinplava, is a human monoclonal antibody designed for the prevention of recurrence of Clostridioides difficile infections.   Wikipedia

More Chemistry

Drug Pricing (per unit)

United States

$2791.2700 - $3819.0500
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

bezlotoxumab | gs-cda1 | mdx-1388 | mk-6072 | zinplava


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue